WASF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.420300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.182200E-02
Normal-vs-Stage2
3.423700E-02
Normal-vs-Stage3
3.198200E-02
Normal-vs-Stage4
2.124400E-01
Stage1-vs-Stage2
5.681200E-01
Stage1-vs-Stage3
5.761200E-01
Stage1-vs-Stage4
3.365400E-01
Stage2-vs-Stage3
2.876200E-01
Stage2-vs-Stage4
5.321400E-01
Stage3-vs-Stage4
2.106800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.615800E-02
Normal-vs-AfricanAmerican
1.200590E-01
Normal-vs-Asian
4.226200E-02
Caucasian-vs-AfricanAmerican
6.576400E-01
Caucasian-vs-Asian
3.720000E-01
AfricanAmerican-vs-Asian
4.038000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.651560E-02
Normal-vs-Female
4.483500E-02
Male-vs-Female
2.941400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.184500E-02
Normal-vs-Age(41-60Yrs)
3.928300E-02
Normal-vs-Age(61-80Yrs)
2.146400E-02
Normal-vs-Age(81-100Yrs)
3.919800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.648200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.912200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.827000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.520800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.797500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.080440E-02
Normal-vs-Daily Drinker
7.159800E-03
Normal-vs-Weekly Drinker
1.285570E-01
Normal-vs-Occasional Drinker
4.472200E-02
Normal-vs-Social Drinker
7.382400E-02
Non Drinker-vs-Daily Drinker
6.745200E-01
Non Drinker-vs-Weekly Drinker
2.271600E-01
Non Drinker-vs-Occasional Drinker
1.200850E-01
Non Drinker-vs-Social Drinker
7.732100E-02
Daily Drinker-vs-Weekly Drinker
3.614400E-01
Daily Drinker-vs-Occasional Drinker
2.163800E-01
Daily Drinker-vs-Social Drinker
1.327240E-01
Weekly Drinker-vs-Occasional Drinker
9.428800E-01
Weekly Drinker-vs-Social Drinker
7.480400E-01
Occasional Drinker-vs-Social Drinker
7.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.669400E-01
Normal-vs-Grade 2
8.657800E-01
Normal-vs-Grade 3
9.364200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.061100E-03
Grade 1-vs-Grade 3
1.585380E-01
Grade 1-vs-Grade 4
9.669400E-01
Grade 2-vs-Grade 3
1.566840E-01
Grade 2-vs-Grade 4
8.657800E-01
Grade 3-vs-Grade 4
9.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.229900E-02
Normal-vs-NonDiabetic
1.990000E-02
Diabetic-vs-NonDiabetic
3.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.591000E-01
Normal-vs-NoPancreatitis
1.003990E-02
Pancreatitis-vs-NoPancreatitis
2.747700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.130200E-02
Normal-vs-N1
3.059600E-02
N0-vs-N1
3.808200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.876100E-02
Normal-vs-TP53-NonMutant
3.114100E-02
TP53-Mutant-vs-TP53-NonMutant
1.133640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
